Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Real-time sun protection decisions in first-degree relatives of melanoma patients.

Hay JL, Shuk E, Schofield E, Loeb R, Holland S, Burkhalter J, Li Y.

Health Psychol. 2017 Sep;36(9):907-915. doi: 10.1037/hea0000523.

PMID:
28846008
2.

Measurement invariance of intuitive cancer risk perceptions across diverse populations: The Cognitive Causation and Negative Affect in Risk scales.

Baser RE, Li Y, Brennessel D, Kemeny MM, Hay JL.

J Health Psychol. 2017 Feb 1:1359105317693910. doi: 10.1177/1359105317693910. [Epub ahead of print]

PMID:
28810422
3.

Tanning and Teens: Is Indoor Exposure the Tip of the Iceberg?

Hay JL, Riley KE, Geller AC.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1170-1174. doi: 10.1158/1055-9965.EPI-17-0095.

PMID:
28765337
4.

Commentary on the MID3 Good Practices Paper.

Manolis E, Brogren J, Cole S, Hay JL, Nordmark A, Karlsson KE, Lentz F, Benda N, Wangorsch G, Pons G, Zhao W, Gigante V, Serone F, Standing JF, Dokoumetzidis A, Vakkilainen J, van den Heuvel M, Mangas Sanjuan V, Taminiau J, Kerwash E, Khan D, Musuamba FT, Skottheim Rusten I; EMA Modelling and Simulation Working Group.

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):416-417. doi: 10.1002/psp4.12223. Epub 2017 Jul 22.

5.

Interest and Attitudes of Patients With Advanced Cancer With Regard to Secondary Germline Findings From Tumor Genomic Profiling.

Hamilton JG, Shuk E, Genoff MC, Rodríguez VM, Hay JL, Offit K, Robson ME.

J Oncol Pract. 2017 Jul;13(7):e590-e601. doi: 10.1200/JOP.2016.020057. Epub 2017 Jun 19.

PMID:
28628391
6.

Recognizing Latinos' range of skin pigment and phototypes to enhance skin cancer prevention.

Robinson JK, Penedo FJ, Hay JL, Jablonski NG.

Pigment Cell Melanoma Res. 2017 Sep;30(5):488-492. doi: 10.1111/pcmr.12598. Epub 2017 Jul 4.

PMID:
28504868
7.

Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial.

Hay JL, Berwick M, Zielaskowski K, White KA, Rodríguez VM, Robers E, Guest DD, Sussman A, Talamantes Y, Schwartz MR, Greb J, Bigney J, Kaphingst KA, Hunley K, Buller DB.

JMIR Res Protoc. 2017 Apr 25;6(4):e52. doi: 10.2196/resprot.7158.

8.

All in the family? Communication of cancer survivors with their families.

Bowen DJ, Hay JL, Harris-Wai JN, Meischke H, Burke W.

Fam Cancer. 2017 Apr 3. doi: 10.1007/s10689-017-9987-8. [Epub ahead of print]

PMID:
28374161
9.

Patient perspectives on ipilimumab across the melanoma treatment trajectory.

Shuk E, Shoushtari AN, Luke J, Postow MA, Callahan M, Harding JJ, Roth KG, Flavin M, Granobles A, Christian J, Gold G, Schoenhammer M, Gordon M, Cimaglia N, Dyson R, Goodman-Davis N, Colgan MN, Jefferson IS, Munhoz R, D'Angelo S, Wolchok J, Chapman P, Chi P, Carvajal RD, Hay JL.

Support Care Cancer. 2017 Jul;25(7):2155-2167. doi: 10.1007/s00520-017-3621-z. Epub 2017 Mar 1.

PMID:
28247127
10.

Friendly tanning: young adults' engagement with friends around indoor tanning.

Rodríguez VM, Daniel CL, Welles BF, Geller AC, Hay JL.

J Behav Med. 2017 Aug;40(4):631-640. doi: 10.1007/s10865-017-9832-4. Epub 2017 Feb 8.

PMID:
28181003
11.

Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.

Hamilton JG, Genoff MC, Salerno M, Amoroso K, Boyar SR, Sheehan M, Fleischut MH, Siegel B, Arnold AG, Salo-Mullen EE, Hay JL, Offit K, Robson ME.

Breast Cancer Res Treat. 2017 Apr;162(2):297-306. doi: 10.1007/s10549-017-4123-x. Epub 2017 Feb 1.

PMID:
28150129
12.

The urgent need to ban youth indoor tanning: evidence from college undergraduates.

Daniel CL, Hay JL, Welles BF, Geller AC.

Transl Behav Med. 2017 Jan 31. doi: 10.1007/s13142-017-0469-1. [Epub ahead of print] No abstract available.

PMID:
28144835
13.

Pharmacokinetics and pharmacodynamics of intrathecally administered Xen2174, a synthetic conopeptide with norepinephrine reuptake inhibitor and analgesic properties.

Okkerse P, Hay JL, Sitsen E, Dahan A, Klaassen E, Houghton W, Groeneveld GJ.

Br J Clin Pharmacol. 2017 Apr;83(4):751-763. doi: 10.1111/bcp.13176. Epub 2016 Dec 16.

PMID:
27987228
14.

Measuring blood-brain barrier penetration using the NeuroCart, a CNS test battery.

Groeneveld GJ, Hay JL, Van Gerven JM.

Drug Discov Today Technol. 2016 Jun;20:27-34. doi: 10.1016/j.ddtec.2016.07.004. Epub 2016 Oct 21. Review.

15.

"It's Not JUST Skin Cancer": Understanding Their Cancer Experience From Melanoma Survivor Narratives Shared Online.

Banerjee SC, D'Agostino TA, Gordon ML, Hay JL.

Health Commun. 2016 Dec 16:1-14. doi: 10.1080/10410236.2016.1250707. [Epub ahead of print]

PMID:
27982699
16.

Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care.

Rodríguez VM, Robers E, Zielaskowski K, Javier González C, Hunley K, Kaphingst KA, Guest DD, Sussman A, Meyer White KA, Schwartz MR, Greb J, Talamantes Y, Bigney J, Berwick M, Hay JL.

J Community Genet. 2017 Jan;8(1):53-63. doi: 10.1007/s12687-016-0287-z. Epub 2016 Dec 6.

17.

Relationship between physician-adjudicated adverse events and patient-reported health-related quality of life in a phase II clinical trial (NCT01143402) of patients with metastatic uveal melanoma.

Atkinson TM, Hay JL, Shoushtari A, Li Y, Paucar DJ, Smith SC, Kudchadkar RR, Doyle A, Sosman JA, Quevedo JF, Milhem MM, Joshua AM, Linette GP, Gajewski TF, Lutzky J, Lawson DH, Lao CD, Flynn PJ, Albertini MR, Sato T, Lewis K, Marr B, Abramson DH, Dickson MA, Schwartz GK, Carvajal RD.

J Cancer Res Clin Oncol. 2017 Mar;143(3):439-445. doi: 10.1007/s00432-016-2318-x. Epub 2016 Dec 5.

PMID:
27921276
18.

Communication about melanoma and risk reduction after melanoma diagnosis.

Rodríguez VM, Berwick M, Hay JL.

Psychooncology. 2016 Nov 15. doi: 10.1002/pon.4315. [Epub ahead of print]

PMID:
27862570
19.

The use of a battery of pain models to detect analgesic properties of compounds: a two-part four-way crossover study.

Okkerse P, van Amerongen G, de Kam ML, Stevens J, Butt RP, Gurrell R, Dahan A, van Gerven JM, Hay JL, Groeneveld GJ.

Br J Clin Pharmacol. 2017 May;83(5):976-990. doi: 10.1111/bcp.13183. Epub 2017 Jan 9.

PMID:
27862179
20.

Building Materials from Colloidal Nanocrystal Arrays: Evolution of Structure, Composition, and Mechanical Properties upon the Removal of Ligands by O2 Plasma.

Shaw S, Colaux JL, Hay JL, Peiris FC, Cademartiri L.

Adv Mater. 2016 Oct;28(40):8900-8905. doi: 10.1002/adma.201601873. Epub 2016 Aug 23.

PMID:
27550789

Supplemental Content

Support Center